HARVARD BIOSCIENCE, INC. (HBIO) Operating margin 2016–2025
HARVARD BIOSCIENCE, INC. (HBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-56.1%FY2025 · since FY2016: -2.9% → -56.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -56.1% | -49.5 pp |
| FY2024 | -6.6% | -8.3 pp |
| FY2023 | 1.7% | +7.8 pp |
| FY2022 | -6.1% | -7.9 pp |
| FY2021 | 1.7% | +1.5 pp |
| FY2020 | 0.2% | -0.1 pp |
| FY2019 | 0.3% | -0.5 pp |
| FY2018 | 0.8% | +1.6 pp |
| FY2017 | -0.8% | +2.0 pp |
| FY2016 | -2.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More HBIO financial trends
HBIO RevenueHBIO Net incomeHBIO Net marginHBIO Gross profitHBIO Gross marginHBIO Operating incomeHBIO Operating cash flowHBIO Free cash flowHBIO Capital expendituresHBIO Return on equityHBIO Stock buybacksHBIO Dividends paidHBIO Total assetsHBIO Total liabilitiesHBIO Shareholders’ equityHBIO overview →